No Data
No Data
No Data
No Data
No Data
World Awaits Bankman-Fried Sentence, Drug Stock Pump-And-Dump, Penny Stock Fraud: Financial Crimes Weekly
"Thousands of ordinary people lost their savings," said prosecutors in the trial of Sam Bankman-Fried this week, urging the judge to enact the harshest possible punishment when the disgraced founder o
BenzingaMar 24 04:26
Oncology Pharma Inc. (OTCMKTS:ONPH) Sees Significant Increase in Short Interest
Oncology Pharma Inc. (OTCMKTS:ONPH – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 27,300 shares,
Financial News LiveApr 19, 2023 11:03
Oncology Pharma Inc. (OTCMKTS:ONPH) Short Interest Update
Oncology Pharma Inc. (OTCMKTS:ONPH – Get Rating) was the target of a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 22,900 shares, a dr
Financial News LiveMar 3, 2023 12:12
Oncology Pharma Inc. (OTCMKTS:ONPH) Short Interest Up 28.8% in January
Oncology Pharma Inc. (OTCMKTS:ONPH – Get Rating) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 30,400 shares, a growth of 28.8%
kopsourceFeb 15, 2023 08:51
Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development
SAN FRANCISCO, CA / ACCESSWIRE / May 9, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is pleased to execute its next phase with Connect2Trials, Inc. Originally, t
AccesswireMay 9, 2022 19:39
Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer
SAN FRANCISCO, CA / ACCESSWIRE / April 13, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma ("The Company") is pleased to announce that it has completed the initial feasibility phase of its
AccesswireApr 13, 2022 19:35
No Data
No Data